title: Lupus erythematosus-like features in patients with cutaneous T-cell lymphoma.
abstract: BACKGROUND
  The development of lupus erythematosus-like (LE-like) features in patients with cutaneous T-cell lymphoma (CTCL) has not been reported previously in the literature. Both diseases, however, have been etiologically linked to retroviruses.
  
  
  OBJECTIVE
  Our purpose was to report four cases of patients with CTCL who developed LE-like features during the course of their disease, and to evaluate for evidence of antibodies to retroviruses in the sera of these patients.
  
  
  METHODS
  Four patients with biopsy-proven CTCL with clinical or histologic features of systemic lupus erythematosus (SLE) were evaluated for clinical and laboratory criteria for SLE. Only one patient demonstrated four American Rheumatism Association (ARA) criteria sufficient for the diagnosis of SLE. The remaining three patients demonstrated one or two criteria for SLE. In addition, the sera of these patients were examined by Western blot analysis for evidence of human immunodeficiency virus type I (HIV-I), human T-cell lymphotrophic virus type I (HTLV-I), or human intracisternal A-type particle type I (HIAP-I) retroviral proteins. Each patient demonstrated antibodies to some of the retroviral proteins examined. The sera of two patients reacted to proteins for HIAP-I, and the sera of two patients reacted to p24 gag proteins of HIV-I. No patient reacted to HTLV-I proteins.
  
  
  CONCLUSIONS
  Our report identifies four patients with CTCL who developed LE-like features during the course of their disease. Although the etiology of CTCL and SLE has not been well established, each has been linked to retroviruses. Evidence of antibodies to retroviral proteins was identified in each of our patients by Western blot analysis. Although the clinical and laboratory findings in these cases do not resolve the etiologic role of retroviruses in CTCL or SLE, they suggest that retroviruses may have a role in the pathogenesis of the clinical phenomenon reported in these four patients.
authors.affiliation: Department of Dermatology, Louisiana State University School of Medicine, New Orleans, USA.
authors.forename: E I
authors.initials: EI
authors.lastname: McBurney
authors.forename: P R
authors.initials: PR
authors.lastname: Hickham
authors.forename: R F
authors.initials: RF
authors.lastname: Garry
authors.forename: R J
authors.initials: RJ
authors.lastname: Reed
mesh_terms: D000368:Aged; D015153:Blotting, Western; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D015483:HIV Antibodies / Q000032:analysis; D015658:HIV Infections / Q000150:complications / Q000821:virology; D015497:HIV-1 / Q000276:immunology; D015481:HTLV-I Antibodies / Q000032:analysis; D015490:HTLV-I Infections / Q000150:complications / Q000821:virology; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000150:complications* / Q000473:pathology / Q000821:virology; D016410:Lymphoma, T-Cell, Cutaneous / Q000150:complications* / Q000473:pathology / Q000821:virology; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000032:analysis; D012867:Skin / Q000473:pathology; D051636:X-Linked Inhibitor of Apoptosis Protein
chemical_list: D015483:HIV Antibodies; D015481:HTLV-I Antibodies; D011506:Proteins; D051636:X-Linked Inhibitor of Apoptosis Protein; C496866:XIAP protein, human